NCT07111936Recruiting
Evaluating the Impact of CONNECT in a Multilingual Population
Evaluating the Impact of CONNECT, a Novel Smoking Cessation Intervention, in a Diverse, Multilingual Population
Source: ClinicalTrials.gov · Last updated 13 Aug 2026
Brief summary (registry, in English)
This study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a video doctor with personalized responses, text message and telephone call support and connection with a pharmacist to assist in obtaining nicotine replacement medication. This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current adult smokers within the Spanish and Cantonese speaking communities.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 439 (estimated)
- First submitted
- 1 Aug 2025
- Start date
- 7 Aug 2025
- Primary completion date
- 31 Mar 2028
- Lead sponsor
- University of California, San Francisco
- Diseases
- Lung cancer
- NCT number
- NCT07111936
What you commit to
- Study type: Interventional
- Planned participants: 439
- From 7 Aug 2025 to the primary completion date, 31 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals receiving hospice care.
- Hearing and/or vision disabilities that would prevent participants from adequately receiving treatment components such as video or telephone counseling.
Other illness
- Individuals with a diagnosis of lung cancer.
- Individuals whose providers do not think that they should participate (e.g., psychiatric illness or significant cognitive impairment that would impede the individuals ability to participate).
Other
- Non-smokers.
Who the study is looking for
- Age 50-80 years old.
- Current smokers defined at smoking at least one cigarette in past 7 days AND eligible for lung cancer screening (LCS) based on smoking history (\>=20 pack year history)
- California (CA) residents
- Able to understand and comply with study procedures for the entire length of the study.
- Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
Age in the registry: 50 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.